505 related articles for article (PubMed ID: 21651357)
1. Inflammatory bowel disease: beyond the boundaries of the bowel.
Actis GC; Rosina F; Mackay IR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
3. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
Reuter BK; Pizarro TT
Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
[TBL] [Abstract][Full Text] [Related]
4. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
5. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
Abraham C; Cho JH
Annu Rev Med; 2009; 60():97-110. PubMed ID: 18976050
[TBL] [Abstract][Full Text] [Related]
6. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms.
Balding J; Livingstone WJ; Conroy J; Mynett-Johnson L; Weir DG; Mahmud N; Smith OP
Mediators Inflamm; 2004 Jun; 13(3):181-7. PubMed ID: 15223609
[TBL] [Abstract][Full Text] [Related]
8. Extraintestinal considerations in inflammatory bowel disease.
Levine JB; Lukawski-Trubish D
Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
11. Immunopathogenesis of inflammatory bowel disease: current concepts.
Bamias G; Cominelli F
Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
[TBL] [Abstract][Full Text] [Related]
12. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor RB
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
[TBL] [Abstract][Full Text] [Related]
14. Joint involvement associated with inflammatory bowel disease.
De Vos M
Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
[TBL] [Abstract][Full Text] [Related]
15. Extraintestinal manifestations of inflammatory bowel disease.
Urlep D; Mamula P; Baldassano R
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
[TBL] [Abstract][Full Text] [Related]
16. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
Goyette P; Labbé C; Trinh TT; Xavier RJ; Rioux JD
Ann Med; 2007; 39(3):177-99. PubMed ID: 17457716
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
19. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
Apgar JT
Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB in inflammatory bowel disease.
Atreya I; Atreya R; Neurath MF
J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
